A new network will collect and analyze data on adverse events associated with blood transfusions in an effort to improve patient safety.
The U.S. Biovigilance Network plans to launch a pilot involving nine hospitals nationwide this fall, with a full system launch expected in 2009. The network is a private/public collaborative funded with an initial $1 million in private donations. The HHS and the Centers for Disease Control and Prevention are providing the platform for initial surveillance though the National Healthcare Safety Network.
The U.S. Biovigilance Network will allow us to see whats happening in transfusion and transplantation, use experts to analyze the situation and recommend improvements in the system leading to augmented patient safety, James AuBuchon, chair of pathology at the Dartmouth-Hitchcock Medical Center, Lebanon, N.H., which is participating in the network, said in a written statement.
The United States is the only developed nation without a national system to track and monitor the safety of blood collection and transfusion, instead relying on data from other countries and by tracking outcomes from individual hospitals, transfusion centers and blood suppliers, according to the American Association of Blood Banks, which is spearheading the new network. -- by Rebecca Vesely
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.